Successful use of veno-arterial extracorporeal membrane oxygenation in a patient with high-risk pulmonary embolism and cardiogenic shock during sickle-cell crisis: a case report

Clicks: 2
ID: 339965
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #424 of 429 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 429 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background Sickle cell disease, the most common hereditary hemolytic disorder worldwide, is characterized by recurrent hemolytic and vaso-occlusive crises that are responsible for much of its morbidity and mortality. Data on the management of cardiogenic shock in the setting of sickle cell crisis is limited, especially with regards to mechanical circulatory support. Case summary We present the case of a 23-year-old male with sickle cell disease and a history of allogeneic hematopoietic stem cell transplantation, who initially presented to the hospital due to recurrent pain exacerbation. The clinical course was complicated by a high-risk pulmonary embolism during a sickle cell crisis, resulting in rapid cardiopulmonary deterioration and refractory shock, for which veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was successfully employed as rescue therapy. VA-ECMO support was successfully weaned after two days, follow-up assessment six months later demonstrated substantial recovery of both left and right ventricular systolic function. Despite multiple intracranial hemorrhages and markedly elevated neuron-specific enolase levels during VA-ECMO support, both strong predictors of poor neurological outcome, the patient was discharged without neurological deficits. Discussion This case demonstrates the potential role of VA-ECMO as a feasible rescue strategy in carefully selected patients with sickle cell disease who develop refractory shock secondary to pulmonary embolism. Furthermore, markedly elevated neuron-specific enolase levels should be interpreted with caution in the setting of chronic hemolysis, as they may overestimate the extent of hypoxic-ischemic brain injury and thereby limit their prognostic value for neurological outcome.
Reference Key
openalex_W7231040298 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag858
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.